Dec 1, 2015

CardioCell Plans Phase IIb Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure

CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, intends to proceed with finalizing a Phase IIb clinical trial protocol based on recommendations from a Heart Failure Advisory Board comprising cardiology key opinion leaders and its Scientific Advisory Board members. READ FULL ARTICLE